Chengdu Kanghua Biological Products (300841) — Cash Flow Reinvestment Rate
Chengdu Kanghua Biological Products (300841) has a Cash Flow Reinvestment Rate of 0.16x as of September 2025, reinvesting CN¥14.49 Million (capex CN¥14.49 Million ) from operating cash flow of CN¥92.89 Million. See how much free cash does Chengdu Kanghua Biological Products generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Kanghua Biological Products Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Chengdu Kanghua Biological Products across 10 annual periods. For the full cash flow conversion analysis, see 300841 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year capital reinvestment analysis for Chengdu Kanghua Biological Products. See Chengdu Kanghua Biological Products (300841) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | CN¥342.14 Million | CN¥572.24 Million | CN¥144.30 Million | ▲ +7.0% |
| 2023 | 0.56x | CN¥320.66 Million | CN¥573.98 Million | CN¥157.27 Million | ▼ -74.4% |
| 2022 | 2.18x | CN¥425.48 Million | CN¥194.99 Million | CN¥419.23 Million | ▼ -32.9% |
| 2021 | 3.25x | CN¥423.69 Million | CN¥130.33 Million | CN¥314.94 Million | ▲ +170.8% |
| 2020 | 1.20x | CN¥443.67 Million | CN¥369.56 Million | CN¥135.67 Million | ▼ -33.9% |
| 2019 | 1.82x | CN¥332.04 Million | CN¥182.73 Million | CN¥24.04 Million | ▼ -69.6% |
| 2018 | 5.97x | CN¥342.58 Million | CN¥57.35 Million | CN¥34.58 Million | ▲ +71.9% |
| 2017 | 3.47x | CN¥312.53 Million | CN¥89.96 Million | CN¥4.53 Million | ▲ +147.5% |
| 2016 | 1.40x | CN¥3.71 Million | CN¥2.64 Million | CN¥1.86 Million | ▲ +197.4% |
| 2015 | 0.47x | CN¥3.07 Million | CN¥6.51 Million | CN¥3.07 Million | — |